Phase II, multicentric, prospective and opened clinical trial of advanced valganciclovir treatment of CMV in allogenic hematopoietic progenitors transplant
Phase of Trial: Phase II
Latest Information Update: 01 Jun 2011
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 22 Sep 2009 Actual end date (1 Sep 2009) added as reported by ClinicalTrials.gov.
- 22 Sep 2009 Status changed from active, no longer recruiting to completed ass reported by ClinicalTrials.gov
- 20 May 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.